| Business Summary | | St.
Jude
Medical,
Inc.,
together
with
its
subsidiaries,
is
engaged
in
the
development,
manufacturing
and
distribution
of
medical
technology
products
for
the
cardiac
rhythm
management,
cardiology
and
vascular
access,
and
cardiac
surgery
markets.
St.
Jude
has
two
segments,
Cardiac
Rhythm
Management
(CRM)
and
Cardiac
Surgery
(CS,
formerly
known
as
Heart
Valve
Disease
Management).
The
CRM
segment,
which
includes
the
results
from
the
Company's
Cardiac
Rhythm
Management
Division
and
Daig
Division,
develops,
manufactures
and
distributes
bradycardia
pulse
generator
and
tachycardia
implantable
cardioverter
defibrillator
(ICD)
systems,
electrophysiology
and
interventional
cardiology
catheters
and
vascular
closure
devices.
The
CS
segment
develops,
manufactures
and
distributes
mechanical
and
tissue
heart
valves
and
valve
repair
products,
and
suture-free
devices
to
facilitate
coronary
artery
bypass
graft
anastomoses. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | St.
Jude
Medical
designs,
manufactures,
and
markets
medical
devices
primarily
for
cardiac
care.
Products
include
heart
valve
disease
management
devices,
cardiac
rhythm
management
and
interventional
cardiology
devices.
For
the
six
months
ended
6/30/01,
revenues
rose
11%
to
$662.1
million.
Net
income
rose
82%
to
$90.9
million.
Revenues
reflect
higher
bradycardia
and
Angio-Seal
products
sales.
Earnings
also
reflect
the
absence
of
a
$26.1
million
special
charge. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Ronald Matricaria, 58 Chairman | $1.1M | $281K | Terry Shepherd, 48 CEO,
Director | 1.1M | -- | Daniel Starks, 46 Pres,
COO, Director | 707K | -- | John Heinmiller, 46 VP-
Fin., CFO | 471K | -- | Kevin O'Malley, 49 VP,
Gen. Counsel | 446K | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|